These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39067896)

  • 1. CAR T-cell perspectives in lupus.
    Gremese E; Bruno D; Ferraccioli G
    Lancet; 2024 Jul; 404(10450):336. PubMed ID: 39067896
    [No Abstract]   [Full Text] [Related]  

  • 2. CAR T-cell perspectives in lupus - Authors' reply.
    Schett G; Mackensen A; Mougiakakos D
    Lancet; 2024 Jul; 404(10450):336-337. PubMed ID: 39067897
    [No Abstract]   [Full Text] [Related]  

  • 3. CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?
    van Leuven SI; Duivenvoorden R
    Rheumatology (Oxford); 2024 May; 63(5):1192-1194. PubMed ID: 38377390
    [No Abstract]   [Full Text] [Related]  

  • 4. CAR-T-Cell Therapy for Systemic Lupus Erythematosus: A Comprehensive Overview.
    Abdalhadi HM; Chatham WW; Alduraibi FK
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR T-Cell Therapy in Autoimmune Disease. Reply.
    Müller F; Mackensen A; Schett G
    N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
    [No Abstract]   [Full Text] [Related]  

  • 6. CAR T-Cell Therapy in Autoimmune Disease.
    Howard JF; Vu T; Mozaffar T
    N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
    [No Abstract]   [Full Text] [Related]  

  • 7. CAR T-Cell Therapy in Autoimmune Disease.
    Merkt W; Lorenz HM; Schmitt M
    N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
    [No Abstract]   [Full Text] [Related]  

  • 8. CAR T-Cell Therapy in Autoimmune Disease.
    De Benedetti F; Diomedi Camassei F; Locatelli F
    N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
    [No Abstract]   [Full Text] [Related]  

  • 9. Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production.
    Dingfelder J; Aigner M; Taubmann J; Minopoulou I; Park S; Kaplan CD; Cheng JK; Van Blarcom T; Schett G; Mackensen A; Lutzny-Geier G
    Transplant Cell Ther; 2024 Jun; 30(6):582.e1-582.e10. PubMed ID: 38548226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
    Ghassemi S; Milone MC
    J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy.
    Guffroy A; Jacquel L; Guffroy B; Martin T
    Joint Bone Spine; 2024 Sep; 91(5):105702. PubMed ID: 38336271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dawn of CAR-T cell therapy in autoimmune diseases.
    Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
    Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
    Lyu X; Gupta L; Tholouli E; Chinoy H
    Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?
    Stojkic I; Harper L; Coss S; Kallash M; Driest K; Lamb M; Ardoin SP; Akoghlanian S
    Pediatr Rheumatol Online J; 2024 Aug; 22(1):72. PubMed ID: 39118067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trials and tribulations of CAR-T cell development for cancer and AIDS.
    Hege K
    Nat Med; 2019 Aug; 25(8):1183. PubMed ID: 31388173
    [No Abstract]   [Full Text] [Related]  

  • 16. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Antigen Receptor (CAR) T-Cell Therapy.
    Pagel JM; West HJ
    JAMA Oncol; 2017 Nov; 3(11):1595. PubMed ID: 28880983
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE.
    Li M; Zhang Y; Jiang N; Ning C; Wang Q; Xu D; Wang Z; Lv L; Zhou D; Zeng X
    N Engl J Med; 2024 Jul; 391(4):376-378. PubMed ID: 39047248
    [No Abstract]   [Full Text] [Related]  

  • 19. CAR T-cells for relapsed B-cell ALL in adults.
    Gilbert JA
    Lancet Oncol; 2018 Mar; 19(3):e143. PubMed ID: 29429915
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of academic CAR T cells.
    Delgado J; Juan M; Calvo G; Urbano-Ispizua Á
    Lancet Haematol; 2024 Jul; 11(7):e484-e485. PubMed ID: 38937023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.